Dopaminergic differentiation of grafted GFP transgenic neuroepithelial stem cells in the brain of a rat model of Parkinson's disease

Neuroscience Letters

Volumn 420, Issue 1, 2007, Pages 23-28

  Sun, Jinhao ^a   Gao, Qing ^a   Miller, Katherine ^b   Wang, Xian ^a   Wang, Jiazeng ^a   Liu, Wenjing ^a   Bao, Lihua ^a   Zhang, Jing ^a   Zhang, Liping ^a   Poon, W S ^c   Gao, Yingmao ^a  

^a SHANDONG UNIVERSITY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

GFP; Neuroepithelial cells; Parkinson's disease; Transgenic

Indexed keywords

GREEN FLUORESCENT PROTEIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; GLIA; NERVE CELL; NEURAL TUBE; NEUROEPITHELIAL STEM CELL; NEUROEPITHELIUM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEM CELL; STEM CELL TRANSPLANTATION; TRANSGENICS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; DOPAMINE; EPITHELIAL CELLS; GREEN FLUORESCENT PROTEINS; NEURONS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; STEM CELLS; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE;

EID: 34249016435     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.03.058     Document Type: Article

References (20)

1. Abercrombie M. Estimation of nuclear populations from microtome sections. Anat. Rec. 94 (1946) 239-247
2. Borlongan C.V. Transplantation therapy for Parkinson's disease. Expert Opin. Investig. Drugs 9 (2000) 2319-2330
3. Borlongan C.V., and Sanberg P.R. Neural transplantation for treatment of Parkinson's disease. Drug Discov. Today 7 (2002) 674-682
4. Borlongan C.V., Saporta S., Poulos S.G., Othberg A., and Sanberg P.R. Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats. NeuroReport 9 (1998) 2837-2842
5. Freed C.R. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?. Proc. Natl. Acad. Sci. USA 99 (2002) 1755-1757
6. Freeman T.B., Olanow C.W., Hauser R.A., Nauert G.M., Smith D.A., Borlongan C.V., Sanberg P.R., Holt D.A., Kordower J.H., Vingerhoets F.J., Snow B.J., Caine D., and Gauger L.L. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38 (1995) 379-388
7. Hornykiewicz O. Parkinson's disease: from brain homogenate to treatment. Fed. Proc. 32 (1973) 183-190
8. Lang A.E., and Lozano A.M. Parkinson's disease. First of two parts. N. Engl. J. Med. 339 (1998) 1044-1053
9. Lang A.E., and Lozano A.M. Parkinson's disease. Second of two parts. N. Engl. J. Med. 339 (1998) 1130-1143
10. Mendez I., Sanchez-Pernaute R., Cooper O., Vinuela A., Ferrari D., Bjorklund L., Dagher A., and Isacson O. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128 (2005) 1498-1510
11. Nikkhah G., Cunningham M.G., Jodicke A., Knappe U., and Bjorklund A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 633 (1994) 133-143
12. Palmer T.D., Markakis E.A., Willhoite A.R., Safar F., and Gage F.H. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J. Neurosci. 19 (1999) 8487-8497
13. Sawamoto K., Nakao N., Kakishita K., Ogawa Y., Toyama Y., Yamamoto A., Yamaguchi M., Mori K., Goldman S.A., Itakura T., and Okano H. Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. J. Neurosci. 21 (2001) 3895-3903
14. Snyder E.Y., Daley G.Q., and Goodell M. Taking stock and planning for the next decade: realistic prospects for stem cell therapies for the nervous system. J. Neurosci. Res. 76 (2004) 157-168
15. Sonntag K.C., Simantov R., and Isacson O. Stem cells may reshape the prospect of Parkinson's disease therapy. Brain Res. Mol. Brain Res. 134 (2005) 34-51
16. Sun J.H., Gao Y.M., Yang L., Li Z.H., Lu G., and Yew D. Neural tube-derived neuroepithelial stem cells: a new transplant resource for Parkinson's disease. Neuroreport 18 (2007) 543-547
17. Svendsen C.N., Clarke D.J., Rosser A.E., and Dunnett S.B. Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp. Neurol. 137 (1996) 376-388
18. Uchida K., Momiyama T., Okano H., Yuzaki M., Koizumi A., Mine Y., and Kawase T. Potential functional neural repair with grafted neural stem cells of early embryonic neuroepithelial origin. Neurosci. Res. 52 (2005) 276-286
19. Uchida K., Roach A.H., Kawaja M.D., and Toya S. Successful survival of grafted transgenic neural plate cells in adult central nervous system environment. Cell Mol. Neurobiol. 19 (1999) 79-86
20. Yamada M., Uchida K., Hayashi T., Mine Y., and Kawase T. Vigorous neuronal differentiation of amplified and grafted basic fibroblast growth factor-responsive neurospheres derived from neuroepithelial stem cells. Cell Transplant. 13 (2004) 421-428